At TailorMed, we harness the power of patient-derived organoids to revolutionise cancer treatment. Our cutting-edge technology allows personalised prediction of treatment response, enabling clinicians to tailor therapies with greater precision and efficacy. Committed to improving patient outcomes and survival, our multidisciplinary team of biomedical scientists, clinicians, and AI engineers, bridges the gap between research and clinical application.
Our Mission & Vision
To revolutionise cancer treatment through innovative and patient-specific models. By advancing organoid technology, we are devoted establishing a cutting-edge organoid platform for accurate prediction of individual treatment response, and providing high-quality products to facilitate organoid application in cancer research. Our aim is to improve quality of life for cancer patients worldwide, and ultimately curing cancer.